---
figid: PMC9271392__agmr-22-0036f6
figtitle: Importance of Sclerostin as Bone-Muscle Mediator Crosstalk
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Adeno-associated virus
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
pmcid: PMC9271392
filename: agmr-22-0036f6.jpg
figlink: /pmc/articles/PMC9271392/figure/f6-agmr-22-0036/
number: F6
caption: Mechanism of sclerostin as inhibitor of Wnt4 signaling in muscle via Wnt/β-catenin
  signaling pathway and Wnt4’s effect to myostatin.,,,,,) (Left and center) Wnt4 bone
  and muscle crosstalk occurs via the Wnt/β-catenin signaling pathway, which inhibit
  by sclerostin. Wnt4 overexpression increased Myf5 expression, which is necessary
  for myogenesis. (Right) Myostatin is also thought to be involved in the Wnt4 pathway.
  Wnt4 induces myogenesis by inhibiting myostatin thus preventing muscle wasting and
  cachexia. Myf5, myogenic factor 5; LRP, lipoprotein receptor-related protein; GSK3,
  glycogen synthase kinase 3; APC, adenomatous polyposis coli; Dsh, disheveled; TCF/LEF,
  T-cell factor/lymphoid enhancer factor.
papertitle: Importance of Sclerostin as Bone-Muscle Mediator Crosstalk.
reftext: I Gusti Putu Suka Aryana, et al. Ann Geriatr Med Res. 2022 Jun;26(2):72-82.
year: '2022'
doi: 10.4235/agmr.22.0036
journal_title: Annals of Geriatric Medicine and Research
journal_nlm_ta: Ann Geriatr Med Res
publisher_name: Korean Geriatrics Society
keywords: Aging | SOST protein | Bone | Muscles
automl_pathway: 0.8884924
figid_alias: PMC9271392__F6
figtype: Figure
redirect_from: /figures/PMC9271392__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9271392__agmr-22-0036f6.html
  '@type': Dataset
  description: Mechanism of sclerostin as inhibitor of Wnt4 signaling in muscle via
    Wnt/β-catenin signaling pathway and Wnt4’s effect to myostatin.,,,,,) (Left and
    center) Wnt4 bone and muscle crosstalk occurs via the Wnt/β-catenin signaling
    pathway, which inhibit by sclerostin. Wnt4 overexpression increased Myf5 expression,
    which is necessary for myogenesis. (Right) Myostatin is also thought to be involved
    in the Wnt4 pathway. Wnt4 induces myogenesis by inhibiting myostatin thus preventing
    muscle wasting and cachexia. Myf5, myogenic factor 5; LRP, lipoprotein receptor-related
    protein; GSK3, glycogen synthase kinase 3; APC, adenomatous polyposis coli; Dsh,
    disheveled; TCF/LEF, T-cell factor/lymphoid enhancer factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Myod1
  - Myf5
  - Myf6
  - Wnt4
  - Shh
  - Axin1
  - Apc
  - Gsk3b
  - Ctnnb1
  - Lrp1
  - Mvp
  - Txlng
  - Smad2
  - Trim63
  - Nrg3
  - Ssr1
  - Cs
  - Wnt2
  - Ptpra
  - MYOD1
  - MYF5
  - MYF6
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ADAR
  - DVL1P1
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - GSK3A
  - GSK3B
  - HNF4A
  - CTNNB1
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - SMAD2
  - TRIM63
  - CS
  - myod1
  - myf5
  - myf6
  - wnt4
  - apc
  - gsk3ba
  - gsk3ab
  - elk4
  - ctnnb1
  - cby1
  - smad2
  - cs
---
